Inicio › Cáncer de páncreas › Texas › Dallas
Ensayos clínicos de Cáncer de páncreas en Dallas, TX
22 estudios para Cáncer de páncreas buscan participantes en centros de Dallas y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
DESTINY-PANTUMOUR04
ReclutandoEstudio observacional
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- y 1 más
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
ReclutandoFase 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
ReclutandoFase 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
ReclutandoFase 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
ReclutandoEstudio observacional
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
ReclutandoEstudio observacional
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 1
- University of Texas Southwestern Medical Center, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
ReclutandoFase 1
- Ut Southwestern, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
ReclutandoFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
ReclutandoFase 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
ReclutandoFase 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
ReclutandoEstudio observacional
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
ReclutandoFase 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
ReclutandoFase 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
ReclutandoFase 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
ReclutandoEstudio observacional
- Methodist Digestive Institute, Dallas
Más información sobre Cáncer de páncreas en MedlinePlus
Ensayos de Cáncer de páncreas en otras ciudades
- Houston, TX61 estudios
- New York City, NY60 estudios
- Boston, MA43 estudios
- Nashville, TN39 estudios
- Los Angeles, CA35 estudios
- St. Louis, MO33 estudios
- Arlington, VA33 estudios
- Baltimore, MD31 estudios
- San Antonio, TX31 estudios
- Philadelphia, PA26 estudios
- Tampa, FL26 estudios
- Durham, NC24 estudios
Otros estudios en Dallas
- Cáncer de seno55 estudios
- Cáncer de pulmón de células no pequeñas52 estudios
- Cáncer metastásico42 estudios
- Fallo cardíaco42 estudios
- Cáncer (todos los tipos)37 estudios
- Cáncer de próstata36 estudios
- Cáncer del colon y del recto33 estudios
- Obesidad30 estudios
- Cáncer de ovario28 estudios
- Cáncer de pulmón27 estudios
- Cáncer de vejiga27 estudios
- Cáncer de endometrio24 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.